JAMES TANDY: Open Payments
NPI 1144325226 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 28 payments from 7 companies in 2025. Trend: 2023 $720 · 2024 $698 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $209 |
| Otsuka America Pharmaceutical, Inc. | 5 | $205 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Noven Therapeutics, LLC | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ABBVIE INC. | 1 | $15 |
Products named: HETLIOZ, REXULTI, Auvelity, TRINTELLIX, Xelstrym, SPRAVATO, VRAYLAR.
Industry payments across IN — which companies pay providers there.
